Advanced radiotherapy for gynecological cancer patients
Efficacy of Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
This study looks at how advanced types of radiotherapy affect women with gynecological cancer to see how well they work and what side effects they might cause.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | Female |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, MI) |
| Trial ID | NCT06306170 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with gynecological tumors who have been treated with advanced radiotherapy techniques, including Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), and Stereotactic Body Radiotherapy (SBRT). The study aims to analyze both acute and late toxicity as well as clinical outcomes such as disease-free survival and overall survival. Data will be collected from patients treated at the IRCCS San Raffaele Scientific Institute from January 2005 to January 2024, allowing for a comprehensive evaluation of treatment effects and prognostic factors.
Who should consider this trial
Good fit: Ideal candidates are gynecological cancer patients over 18 years old who have received advanced radiotherapy techniques.
Not a fit: Patients with other types of tumors or those over 90 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of treatment outcomes and side effects for patients with gynecological cancer undergoing advanced radiotherapy.
How similar studies have performed: Other studies have shown success with advanced radiotherapy techniques, indicating a promising approach in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * gynecologic cancer patients * \>18 years old * treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT) Exclusion Criteria: * other tumors * \> 90 years old
Where this trial is running
Milan, MI
- San Raffaele Scientific Institute — Milan, Mi, Italy (Recruiting)
Study contacts
- Principal investigator: andrei Fodor, MD — IRCCS San Raffaele Scientific Institute
- Study coordinator: Andrei Fodor, MD
- Email: fodor.andrei@hsr.it
- Phone: +390226437634
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.